Bioo Scientific Launches In Vivo siRNA Delivery Reagent
RNAi is a potentially powerful but challenging tool for therapeutics and validation studies. One of the primary challenges of achieving optimal in vivo RNAi is developing an effective in vivo siRNA delivery system. The research team at Bioo Scientific developed MaxSuppressor™ In Vivo RNA-LANCEr II delivery reagent, as a solution to this challenge.
According to Lance Ford, VP of Research and Development at Bioo Scientific, “MaxSuppressor In Vivo RNA-LANCEr II is the culmination of 9 years of research in the RNAi field. The delivery offered by MaxSuppressor In Vivo RNA-LANCEr II is critical to the efficiency of in vivo RNAi experiments.”
In addition to efficiently transforming siRNA, the delivery reagent has been shown to also efficiently deliver miRNA, long dsRNA and other RNAi agents directly into living animals.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.